Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension

Aiko Ogawa, Kazufumi Nakamura, Hiromi Matsubara, Hideki Fujio, Tetsuya Ikeda, Kaoru Kobayashi, Ikuko Miyazaki, Masato Asanuma, Katsumasa Miyaji, Daiji Miura, Kengo Fukushima Kusano, Hiroshi Date, Tohru Ohe

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background - Idiopathic pulmonary arterial hypertension (IPAH) is associated with proliferation of smooth muscle cells (SMCs) in small pulmonary arteries. There is no therapy that specifically inhibits SMC proliferation. Recent studies reported that prednisolone (PSL) inhibits the postangioplasty proliferation of SMCs in atherosclerotic arteries. In this study, we tested the hypothesis that PSL has antiproliferative effects on pulmonary artery SMCs of patients with IPAH. Methods and Results - Pulmonary artery SMCs were harvested from the pulmonary arteries of 6 patients with IPAH who underwent lung transplantation. Control SMCs were obtained from 5 patients with bronchogenic carcinoma who underwent lung lobectomy. After incubation in the presence of platelet-derived growth factor (PDGF), PSL was added at different concentrations and cell proliferation was assessed by 3H-thymidine incorporation. PSL (2×10-4 and 2×10-3 mol/L) significantly inhibited PDGF-stimulated proliferation (P0/G1 to the S phase. This inhibition was associated with increased p27 expression level. PSL (2×104 mol/L) also inhibited PDGF-induced SMC migration. Conclusions - Our results indicate that PSL has an antiproliferative effect on cultured SMCs of pulmonary arteries from patients with IPAH and suggest that PSL may be potentially useful therapeutically in patients with IPAH.

Original languageEnglish
Pages (from-to)1806-1812
Number of pages7
JournalCirculation
Volume112
Issue number12
DOIs
Publication statusPublished - Sep 20 2005

Fingerprint

Prednisolone
Pulmonary Artery
Smooth Muscle Myocytes
Platelet-Derived Growth Factor
Cell Proliferation
Lung Transplantation
Bronchogenic Carcinoma
Familial Primary Pulmonary Hypertension
S Phase
Thymidine
Cell Movement
Arteries
Lung

Keywords

  • Hypertension, pulmonary
  • Muscle, smooth
  • Myocytes
  • Prednisolone

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension. / Ogawa, Aiko; Nakamura, Kazufumi; Matsubara, Hiromi; Fujio, Hideki; Ikeda, Tetsuya; Kobayashi, Kaoru; Miyazaki, Ikuko; Asanuma, Masato; Miyaji, Katsumasa; Miura, Daiji; Kusano, Kengo Fukushima; Date, Hiroshi; Ohe, Tohru.

In: Circulation, Vol. 112, No. 12, 20.09.2005, p. 1806-1812.

Research output: Contribution to journalArticle

Ogawa, Aiko ; Nakamura, Kazufumi ; Matsubara, Hiromi ; Fujio, Hideki ; Ikeda, Tetsuya ; Kobayashi, Kaoru ; Miyazaki, Ikuko ; Asanuma, Masato ; Miyaji, Katsumasa ; Miura, Daiji ; Kusano, Kengo Fukushima ; Date, Hiroshi ; Ohe, Tohru. / Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension. In: Circulation. 2005 ; Vol. 112, No. 12. pp. 1806-1812.
@article{c355d1db24d3489f91f55f58627ec908,
title = "Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension",
abstract = "Background - Idiopathic pulmonary arterial hypertension (IPAH) is associated with proliferation of smooth muscle cells (SMCs) in small pulmonary arteries. There is no therapy that specifically inhibits SMC proliferation. Recent studies reported that prednisolone (PSL) inhibits the postangioplasty proliferation of SMCs in atherosclerotic arteries. In this study, we tested the hypothesis that PSL has antiproliferative effects on pulmonary artery SMCs of patients with IPAH. Methods and Results - Pulmonary artery SMCs were harvested from the pulmonary arteries of 6 patients with IPAH who underwent lung transplantation. Control SMCs were obtained from 5 patients with bronchogenic carcinoma who underwent lung lobectomy. After incubation in the presence of platelet-derived growth factor (PDGF), PSL was added at different concentrations and cell proliferation was assessed by 3H-thymidine incorporation. PSL (2×10-4 and 2×10-3 mol/L) significantly inhibited PDGF-stimulated proliferation (P0/G1 to the S phase. This inhibition was associated with increased p27 expression level. PSL (2×104 mol/L) also inhibited PDGF-induced SMC migration. Conclusions - Our results indicate that PSL has an antiproliferative effect on cultured SMCs of pulmonary arteries from patients with IPAH and suggest that PSL may be potentially useful therapeutically in patients with IPAH.",
keywords = "Hypertension, pulmonary, Muscle, smooth, Myocytes, Prednisolone",
author = "Aiko Ogawa and Kazufumi Nakamura and Hiromi Matsubara and Hideki Fujio and Tetsuya Ikeda and Kaoru Kobayashi and Ikuko Miyazaki and Masato Asanuma and Katsumasa Miyaji and Daiji Miura and Kusano, {Kengo Fukushima} and Hiroshi Date and Tohru Ohe",
year = "2005",
month = "9",
day = "20",
doi = "10.1161/CIRCULATIONAHA.105.536169",
language = "English",
volume = "112",
pages = "1806--1812",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension

AU - Ogawa, Aiko

AU - Nakamura, Kazufumi

AU - Matsubara, Hiromi

AU - Fujio, Hideki

AU - Ikeda, Tetsuya

AU - Kobayashi, Kaoru

AU - Miyazaki, Ikuko

AU - Asanuma, Masato

AU - Miyaji, Katsumasa

AU - Miura, Daiji

AU - Kusano, Kengo Fukushima

AU - Date, Hiroshi

AU - Ohe, Tohru

PY - 2005/9/20

Y1 - 2005/9/20

N2 - Background - Idiopathic pulmonary arterial hypertension (IPAH) is associated with proliferation of smooth muscle cells (SMCs) in small pulmonary arteries. There is no therapy that specifically inhibits SMC proliferation. Recent studies reported that prednisolone (PSL) inhibits the postangioplasty proliferation of SMCs in atherosclerotic arteries. In this study, we tested the hypothesis that PSL has antiproliferative effects on pulmonary artery SMCs of patients with IPAH. Methods and Results - Pulmonary artery SMCs were harvested from the pulmonary arteries of 6 patients with IPAH who underwent lung transplantation. Control SMCs were obtained from 5 patients with bronchogenic carcinoma who underwent lung lobectomy. After incubation in the presence of platelet-derived growth factor (PDGF), PSL was added at different concentrations and cell proliferation was assessed by 3H-thymidine incorporation. PSL (2×10-4 and 2×10-3 mol/L) significantly inhibited PDGF-stimulated proliferation (P0/G1 to the S phase. This inhibition was associated with increased p27 expression level. PSL (2×104 mol/L) also inhibited PDGF-induced SMC migration. Conclusions - Our results indicate that PSL has an antiproliferative effect on cultured SMCs of pulmonary arteries from patients with IPAH and suggest that PSL may be potentially useful therapeutically in patients with IPAH.

AB - Background - Idiopathic pulmonary arterial hypertension (IPAH) is associated with proliferation of smooth muscle cells (SMCs) in small pulmonary arteries. There is no therapy that specifically inhibits SMC proliferation. Recent studies reported that prednisolone (PSL) inhibits the postangioplasty proliferation of SMCs in atherosclerotic arteries. In this study, we tested the hypothesis that PSL has antiproliferative effects on pulmonary artery SMCs of patients with IPAH. Methods and Results - Pulmonary artery SMCs were harvested from the pulmonary arteries of 6 patients with IPAH who underwent lung transplantation. Control SMCs were obtained from 5 patients with bronchogenic carcinoma who underwent lung lobectomy. After incubation in the presence of platelet-derived growth factor (PDGF), PSL was added at different concentrations and cell proliferation was assessed by 3H-thymidine incorporation. PSL (2×10-4 and 2×10-3 mol/L) significantly inhibited PDGF-stimulated proliferation (P0/G1 to the S phase. This inhibition was associated with increased p27 expression level. PSL (2×104 mol/L) also inhibited PDGF-induced SMC migration. Conclusions - Our results indicate that PSL has an antiproliferative effect on cultured SMCs of pulmonary arteries from patients with IPAH and suggest that PSL may be potentially useful therapeutically in patients with IPAH.

KW - Hypertension, pulmonary

KW - Muscle, smooth

KW - Myocytes

KW - Prednisolone

UR - http://www.scopus.com/inward/record.url?scp=25444439252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444439252&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.105.536169

DO - 10.1161/CIRCULATIONAHA.105.536169

M3 - Article

VL - 112

SP - 1806

EP - 1812

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 12

ER -